Baxter International Inc.
https://www.baxter.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Baxter International Inc.
For BMS, Launching New Products Is The Start Of The Battle
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve access to lifesaving therapies. Payers and politicians must be persuaded to loosen their purse strings – and open their minds.
BioNTech Ramps Up Spending To Launch 10 Pivotal Cancer Studies In 2024
As COVID-19 vaccine sales decline, the company is investing billions in a diverse oncology pipeline including antibody drug conjugates, immunotherapy and cancer vaccines
BridgeBio Spins Out Cancer Arm With $200m Fundraise
BridgeBio will narrow its focus to rare diseases and the November action date for acoramidis, while subsidiary TheRas will become BridgeBio Oncology Therapeutics, focused on KRAS-targeted drugs.
Finance Watch: Venture Rounds Trend Toward The High End
Private Company Edition: First quarter data again confirm fewer but larger VC rounds in Q1. Big Q2 rounds include a $132.5m series C round for Endeavor Biomedicines, a $103m series A round for Reunion Neuroscience and Enlaza’s $100m series A.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Medical Devices
- Pharmaceuticals
- Services
-
Pharmaceuticals
- Drug Delivery
- Nutraceuticals
-
Medical Devices
- Infusion Therapy Equipment and Supplies
-
Surgical Equipment & Devices
- Surgical Sealants
- Other Names / Subsidiaries
-
- AesRX LLC
- Althin Medical A.B.
- Chatham Therapeutics
- Cheetah Medical
- Claris Injectables Limited
- Fusion Medical Technologies, Inc.
- Gambro AB
- Immuno-US
- Prism Pharmaceuticals, Inc.
- Renal Therapy Services
- SIGMA International Geneeral Medical Apparatus
- SuppreMol GmbH
- Synovis Life Technologies, Inc.
- Wound Care Technologies, Inc.
- Baxter Healthcare Corporation
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice